(NASDAQ: TLPH) Talphera's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 11.09%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.76%.
Talphera's earnings in 2026 is -$14,658,000.On average, 5 Wall Street analysts forecast TLPH's earnings for 2026 to be -$11,835,967, with the lowest TLPH earnings forecast at -$12,220,454, and the highest TLPH earnings forecast at -$10,911,120. On average, 5 Wall Street analysts forecast TLPH's earnings for 2027 to be -$13,072,561, with the lowest TLPH earnings forecast at -$13,748,011, and the highest TLPH earnings forecast at -$10,911,120.
In 2028, TLPH is forecast to generate -$8,126,186 in earnings, with the lowest earnings forecast at -$9,674,526 and the highest earnings forecast at -$5,455,560.